‘A Global Movement For More Democracy In Medicine’ – Formycon Chief Talks Biosimilars Strategy
Formycon CEO Stefan Glombitza Delves Into Detail On Recent Deals, Launches And Pipeline
Characterizing biosimilars as a global movement towards the democratization of medicine, Formycon CEO Stefan Glombitza speaks to Generics Bulletin in detail about the company’s recent deals, launches and key pipeline assets, in the first part of an exclusive two-part interview.
